GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NEPH · Jun 30, 2026

NEPHROS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]

Inspectable configuration

State dimensions

Filing0001493152-26-036851General Corporate

Operating cash generation90thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

11.32% · OPTIONAL · VALID

Revenue growth76thOwn-history percentile · N=17

Evidence method

Yoy · gp.fundamentals.revenue

36.16% · CORE · VALID

Inventory pressure60thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

75.57% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.gross_margin

66.91% · CORE · VALID

Operating margin100thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.operating_margin

20.16% · CORE · VALID

R&D intensity20thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6.08% · OPTIONAL · VALID

SBC intensity5thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.01% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History22 statesSelf-history eligible

Period transition

What moved in the state?

Cash Generation Increased

Previous: -32.06%
Current: 11.32%
Delta: 43.38%

Growth Increased

Previous: 6.87%
Current: 36.16%
Delta: 29.29%

Inventory Pressure Increased

Previous: 69.44%
Current: 75.57%
Delta: 6.13%

Margin Increased

Previous: 57.43%
Current: 66.91%
Delta: 9.49%

Profitability Increased

Previous: 1.86%
Current: 20.16%
Delta: 18.30%

R And D Intensity Decreased

Previous: 6.64%
Current: 6.08%
Delta: -0.56%

Sbc Intensity Decreased

Previous: 1.15%
Current: 1.01%
Delta: -0.14%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Sep 30, 2023

Similarity: 84%
Compared: 6 dimensions
Coverage: 86%

Margin 10.0 · Profitability 0.0 · Sbc Intensity 5.0 · Cash Generation 10.0 · R And D Intensity 20.0 · Inventory Pressure 30.0

Mar 31, 2025

Similarity: 84%
Compared: 7 dimensions
Coverage: 100%

Growth 1.5 · Margin 0.0 · Profitability 0.0 · Sbc Intensity 13.8 · Cash Generation 2.5 · R And D Intensity 1.3 · Inventory Pressure 41.3

Mar 31, 2023

Similarity: 82%
Compared: 6 dimensions
Coverage: 86%

Margin 12.5 · Profitability 0.0 · Sbc Intensity 5.0 · Cash Generation 10.0 · R And D Intensity 20.0 · Inventory Pressure 35.0

Sep 30, 2025

Similarity: 79%
Compared: 7 dimensions
Coverage: 100%

Growth 12.2 · Margin 22.2 · Profitability 5.6 · Sbc Intensity 11.7 · Cash Generation 23.3 · R And D Intensity 30.0 · Inventory Pressure 26.7

Sep 30, 2024

Similarity: 72%
Compared: 7 dimensions
Coverage: 100%

Growth 46.5 · Margin 7.1 · Profitability 0.0 · Sbc Intensity 9.3 · Cash Generation 54.3 · R And D Intensity 20.0 · Inventory Pressure 2.9

Research Graph

Related governed research

Analogous To · NEPH state analogue 3 →Analogous To · NEPH state analogue 1 →Compared To · Surgical & Medical Instruments & Apparatus peers →Analogous To · NEPH state analogue 2 →Analogous To · NEPH state analogue 5 →Analogous To · NEPH state analogue 4 →Transitioned To · NEPH Fundamental State →Transitioned To · NEPH CASH_GENERATION_INCREASED →Transitioned To · NEPH GROWTH_INCREASED →Transitioned To · NEPH INVENTORY_PRESSURE_INCREASED →Transitioned To · NEPH MARGIN_INCREASED →Transitioned To · NEPH PROFITABILITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.